Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04068597
PHASE1/PHASE2

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Sponsor: CellCentric Ltd.

View on ClinicalTrials.gov

Summary

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk Myelodysplastic syndrome.

Official title: An Open-label Phase I/IIa Study to Evaluate the Safety and Efficacy of CCS1477 as Monotherapy and in Combination in Patients With Advanced Haematological Malignancies.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

250

Start Date

2019-08-09

Completion Date

2027-03-31

Last Updated

2025-12-18

Healthy Volunteers

No

Interventions

DRUG

CCS1477

Oral capsule

DRUG

Pomalidomide

oral capsule

DRUG

Dexamethasone

oral tablet

DRUG

Azacitidine

Powder suspension for Injection

DRUG

Venetoclax

Oral tablet

DRUG

Bortezomib

Powder for solution for injection

DRUG

Ixazomib

Oral capsule

DRUG

Elranatamab

Solution for injection

DRUG

Teclistamab

Solution for injection

DRUG

Lenalidomide

Oral capsule

DRUG

Daratumumab

Solution for injection, concentrate for solution for infusion

Locations (39)

Emory Winship Cancer Institute

Atlanta, Georgia, United States

Community Health Network

Indianapolis, Indiana, United States

The Center for Cancer and Blood Disorders (CCBD)

Bethesda, Maryland, United States

Nebraska Cancer Specialists

Omaha, Nebraska, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

Penn Medicine - Abramson Cancer Center Perelman

Philadelphia, Pennsylvania, United States

Institute Bergonie

Bordeaux, France

Gustave Roussy

Villejuif, France

Hospital Germans Trias i Pujol/ ICO Badalona

Badalona, Spain

University Hospital Vall D'Hebron

Barcelona, Spain

Hospital Clínic de Barcelona

Barcelona, Spain

ICO L'Hospitalet (Instituto Catalán de Oncología)

Barcelona, Spain

Hospital Universitario de La Princesa

Madrid, Spain

Hospital Universitario Gregorio Marañón

Madrid, Spain

Hospital Infanta Leonor

Madrid, Spain

Hospital Universitario Ramón y Cajal

Madrid, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

CIOCC Hospital Universitario HM Sanchinarro

Madrid, Spain

Universidad de Navarra

Pamplona, Spain

Hospital Universitario y Politécnico La Fe de la Comunidad Valenciana

Valencia, Spain

Karolinska Comprehensive Cancer Center

Stockholm, Sweden

The Royal Marsden

Sutton, Surrey, United Kingdom

The Clatterbridge Cancer Centre NHS Foundation Trust,

Bebington, United Kingdom

University Hospitals Bristol

Bristol, United Kingdom

University Hospital of Wales

Cardiff, United Kingdom

Royal Derby Hospital

Derby, United Kingdom

Western General Hospital

Edinburgh, United Kingdom

Gartnavel General Hospital

Glasgow, United Kingdom

Leicester Royal Infirmary

Leicester, United Kingdom

St Bartholomew's Hospital

London, United Kingdom

Sarah Cannon Research Institute UK

London, United Kingdom

NIHR University College London Clinical Research Facility

London, United Kingdom

Imperial College

London, United Kingdom

The Christie Hospital

Manchester, United Kingdom

Newcastle upon Tyne Hospitals

Newcastle upon Tyne, United Kingdom

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

Cancer and Haematology Centre

Oxford, United Kingdom

University Hospital of Southampton

Southampton, United Kingdom

Royal Stoke University Hospital

Stoke-on-Trent, United Kingdom